---
figid: PMC3335938__cbt1212_1032_fig001
figlink: /pmc/articles/PMC3335938/figure/F1/
number: F1
caption: Schematic representation of key therapeutic targets in the PI3K/Akt and MAPK
  pathways together with pharmacological agents inhibiting members of these signaling
  cascades. Shown are the key therapeutic targets regulating melanoma development.
  Whereas PI3K/Akt3 pathway involved in cell survival and apoptosis regulation, MAPK
  pathway is implicated in cell proliferation. Targeting members of these signaling
  cascades using pharmacological agents has been shown to inhibit melanoma tumor development.
  Pharmacological agents inhibiting PI3K/Akt signaling; perifosine, 17-AAG, CCI-779
  and RAD-001 have been evaluated in clinical trials. Vemurafenib and sorafenib targeting
  MAPK are also being evaluated in various clinical trials for inhibiting melanomas.
pmcid: PMC3335938
papertitle: The Akt signaling pathway.
reftext: SubbaRao V Madhunapantula, et al. Cancer Biol Ther. 2011 Dec 15;12(12):1032-1049.
pmc_ranked_result_index: '27772'
pathway_score: 0.9565684
filename: cbt1212_1032_fig001.jpg
figtitle: Key therapeutic targets in the PI3K/Akt and MAPK pathways together with
  pharmacological agents inhibiting members of these signaling cascades
year: '2011'
organisms:
- Homo sapiens
ndex: 7253af85-dee7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3335938__cbt1212_1032_fig001.html
  '@type': Dataset
  description: Schematic representation of key therapeutic targets in the PI3K/Akt
    and MAPK pathways together with pharmacological agents inhibiting members of these
    signaling cascades. Shown are the key therapeutic targets regulating melanoma
    development. Whereas PI3K/Akt3 pathway involved in cell survival and apoptosis
    regulation, MAPK pathway is implicated in cell proliferation. Targeting members
    of these signaling cascades using pharmacological agents has been shown to inhibit
    melanoma tumor development. Pharmacological agents inhibiting PI3K/Akt signaling;
    perifosine, 17-AAG, CCI-779 and RAD-001 have been evaluated in clinical trials.
    Vemurafenib and sorafenib targeting MAPK are also being evaluated in various clinical
    trials for inhibiting melanomas.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK3
  - FOXO1
  - PTEN
  - CCND1
  - CREB3L1
  - AKT1S1
  - CREB5
  - CREB3L3
  - BRAF
  - MAPK1
  - PRKCZ
  - BAD
  - MAP2K2
  - PRKCD
  - PRKCQ
  - HRAS
  - AKT3
  - BCL2L1
  - MTOR
  - PRKCI
  - KRAS
  - NRAS
  - ARAF
  - MAP2K1
  - MDM2
  - PRKD3
  - TP53
  - PRKCE
  - PRKCG
  - PRKCH
  - ATF1
  - RPS6KB2
  - RAF1
  - CREB3L4
  - PI3
  - CREB3L2
  - IKBKG
  - PRKCB
  - CREB1
  - ATF2
  - RPS6KB1
  - PDK3
  - PRKCA
  - PDK4
  - CREM
  - IKBKB
  - PDK2
  - CHUK
  - CREB3
  - PDK1
  - Perifosine
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: FKHR/AFX
  symbol: FKHR
  source: hgnc_prev_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: CyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: PRAS40
  symbol: PRAS40
  source: hgnc_alias_symbol
  hgnc_symbol: AKT1S1
  entrez: '84335'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: B-Raf
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Akt3
  symbol: AKT3
  source: hgnc_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Bcl-X
  symbol: Bcl-X
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Mdm2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: (P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB2
  entrez: '6199'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: PI3
  symbol: PI3
  source: hgnc_symbol
  hgnc_symbol: PI3
  entrez: '5266'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: (P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK3
  entrez: '5165'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK4
  entrez: '5166'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK2
  entrez: '5164'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
chemicals:
- word: Perifosine
  source: MESH
  identifier: C105905
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3335938__F1
redirect_from: /figures/PMC3335938__F1
figtype: Figure
---
